National Labs Scramble To Absorb Cuts In DOE Physics Funding

WASHINGTON—Congress last month passed an $18.7 billion-dollar appropriations bill to fund all 1990 research programs sponsored by the Department of Energy. For officials at DOE’s research laboratories, the next move is to figure out how to cope with $31 million less than they had requested. The appropriations bill was intentionally vague, spelling out only $l0 million of the cut. Brookhaven’s Alternating Gradient Synchrotron will get $5 million less for operating costs than

Written byChristopher Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—Congress last month passed an $18.7 billion-dollar appropriations bill to fund all 1990 research programs sponsored by the Department of Energy. For officials at DOE’s research laboratories, the next move is to figure out how to cope with $31 million less than they had requested.

The appropriations bill was intentionally vague, spelling out only $l0 million of the cut. Brookhaven’s Alternating Gradient Synchrotron will get $5 million less for operating costs than it asked for. But lab officials, although unhappy, take pride in the fact that a write-in campaign by those who use the facility staved off a possible cut twice that size. Another $5 million cut was made in high-energy technology, a classification that includes much of the funding for designing new or improved accelerators. Both the Stanford Linear Accelerator Center (SLAC) and Fermilab had hoped to use some of those funds to plan upgrades of existing facilities.

Accelerator ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies